(3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-prop-2-ynylazetidin-2-one
C14H25NO2Si — CID 134918415
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-prop-2-ynylazetidin-2-one
(3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-prop-2-ynylazetidin-2-one (PubChem CID 134918415) has the molecular formula C14H25NO2Si and a molecular weight of 267.44 g/mol. Its IUPAC name is (3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-prop-2-ynylazetidin-2-one.
Molecular Properties
| Compound Name | (3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-prop-2-ynylazetidin-2-one |
|---|---|
| PubChem CID | 134918415 |
| Molecular Formula | C14H25NO2Si |
| Molecular Weight | 267.44 g/mol |
| Exact Mass | 267.17 |
| IUPAC Name | (3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-prop-2-ynylazetidin-2-one |
| SMILES | C#CCC1NC(=O)[C@@H]1[C@@H](C)O[Si](C)(C)C(C)(C)C |
| InChI | InChI=1S/C14H25NO2Si/c1-8-9-11-12(13(16)15-11)10(2)17-18(6,7)14(3,4)5/h1,10-12H,9H2,2-7H3,(H,15,16)/t10-,11?,12-/m1/s1 |
| InChIKey | WTNFLXOEACDPPW-IGBJHFKCSA-N |
| XLogP | 2.53 |
| TPSA | 38.33 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 18 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 267.44 |
| LogP ≤ 5 | 2.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134918415 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.